TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
574,177
|
592,990
|
536,284 |
| Financial expenses |
7,479
|
441
|
13,020 |
| Earnings before taxes |
102,675
|
180,186
|
139,108 |
| EBITDA |
133,032
|
164,402
|
121,746 |
| Total assets |
3,558,818
|
3,158,665
|
3,106,993 |
| Current assets |
926,132
|
665,758
|
552,209 |
| Current liabilities |
332,991
|
157,801
|
204,418 |
| Equity capital |
3,135,999
|
2,918,568
|
2,830,937 |
| - share capital |
1,657
|
1,713
|
1,697 |
| Employees (average) |
256
|
249
|
227 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
88.1%
|
92.4%
|
91.1% |
| Turnover per employee |
2,243
|
2,381
|
2,362 |
| Profit as a percentage of turnover |
17.9%
|
30.4%
|
25.9% |
| Return on assets (ROA) |
3.1%
|
5.7%
|
4.9% |
| Current ratio |
278.1%
|
421.9%
|
270.1% |
| Return on equity (ROE) |
3.3%
|
6.2%
|
4.9% |
| Change turnover |
801
|
53,944
|
291,191 |
| Change turnover % |
0%
|
10%
|
119% |
| Chg. No. of employees |
7
|
22
|
106 |
| Chg. No. of employees % |
3%
|
10%
|
88% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.